An Open Label, Balanced, Randomized, 3×3 Latin Square Design Comparing of Brivaracetam Sustained-release Tablets and Brivaracetam Tablets in the Oral Comparative Pharmacokinetic(PK) Study in Chinese Healthy Adult Subjects Under Fasting Conditions.
Clinical trial NCT05622370 · UNKNOWN
Trial details
- NCT number
- NCT05622370
- Sponsor
- Overseas Pharmaceuticals, Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-13
- Primary completion
- 2023-03-30
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.